Assessment of three equations to calculate plasma LDL cholesterol concentration in fasting and non-fasting hypertriglyceridemic patients
Author:
Vasse Joséphine1, Lassartesse Audrey1, Marmontel Oriane12, Charrière Sybil23, Bouveyron Caroline1, Marrié Nathanaël1, Moulin Philippe23, Di Filippo Mathilde124ORCID
Affiliation:
1. UF Dyslipidémies, Service de Biochimie et de Biologie Moléculaire, Laboratoire de Biologie Médicale MultiSites , Hospices Civils de Lyon Bron , France 2. CarMen Laboratory , INSERM, INRA, Université Claude Bernard Lyon 1 , Pierre-Bénite , France 3. Hospices Civils de Lyon, Fédération d’endocrinologie, maladies métaboliques, diabète et nutrition, Hôpital Louis Pradel , Bron , France 4. Hospices Civils de Lyon, Groupement Hospitalier Est, Centre de Biologie et de Pathologies Est (Aile A3) , Bron Cedex , France
Abstract
Abstract
Objectives
Low-density lipoprotein cholesterol (LDL-C) concentration was calculated for many years using the Friedewald equation, but those from Sampson and extended-Martin-Hopkins perform differently. Their accuracy in fasting hypertriglyceridemia and non-fasting state were compared and the clinical impact of implementing these equations on risk classification and on the setting of lipid treatment goals was assessed.
Methods
Seven thousand six standard lipid profiles and LDL-C concentrations measured after ultracentrifugation (uLDL-C) were retrospectively included. uLDL-C were compared to calculated LDL-C in terms of correlation, root mean square error, residual error, mean absolute deviations and cardiovascular stratification.
Results
In fasting state (n=5,826), Sampson equation was the most accurate, exhibited the highest percentage of residual error lower than 0.13 mmol/L (67 vs. 57 % and 63 % using Friedewald, or extended-Martin-Hopkins equations respectively) and the lowest misclassification rate. However, the superiority of this equation was less pronounced when triglyceride concentration (TG) <4.5 mmol/L were considered. In post-prandial state (n=1,180), extended-Martin-Hopkins was the most accurate equation, exhibited the highest percentage of residual error lower than 0.13 mmol/L (73 vs. 39 % and 57 % using Friedewald and Sampson equation respectively). Overall, the negative bias with Sampson equation may lead to undertreatment. Conversely, a positive bias was observed with extended Martin-Hopkins.
Conclusions
None of the equations tested are accurate when TG>4.52 mmol/L. When TG<4.52 mmol/L both Sampson and Martin-Hopkins equations performed better than Friedewald. The switch to one or the other should take in account their limitations, their ease of implementation into the lab software and the proportion of non-fasting patients.
Publisher
Walter de Gruyter GmbH
Subject
Biochemistry (medical),Clinical Biochemistry,General Medicine
Reference29 articles.
1. Ference, BA, Ginsberg, HN, Graham, I, Ray, KK, Packard, CJ, Bruckert, E, et al.. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 2017;38:2459–72. https://doi.org/10.1093/eurheartj/ehx144. 2. Grundy, SM, Stone, NJ, Bailey, AL, Beam, C, Birtcher, KK, Blumenthal, RS. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation 2018;139:1082–143. https://doi.org/10.1161/CIR.0000000000000625. 3. Mach, F, Baigent, C, Catapano, AL, Koskinas, KC, Casula, M, Badimon, L. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41:111–88. https://doi.org/10.1093/eurheartj/ehz455. 4. Virani, SS, Morris, PB, Agarwala, A, Ballantyne, CM, Birtcher, KK, Kris-Etherton, PM. ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American college of cardiology solution set oversight committee. J Am Coll Cardiol 2021;78:960–93. https://doi.org/10.1016/j.jacc.2021.06.011. 5. Averna, M, Banach, M, Bruckert, E, Drexel, H, Farnier, M, Gaita, D. Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: a statement from a European Atherosclerosis Society Task Force. Atherosclerosis 2021;325:99–109. https://doi.org/10.1016/j.atherosclerosis.2021.03.039.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|